Ontology type: schema:ScholarlyArticle Open Access: True
2017-11-15
AUTHORSThomas Schroeder, Christina Rautenberg, Rainer Haas, Ulrich Germing, Guido Kobbe
ABSTRACTDespite the curative potential of allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), many patients will relapse. Until recently therapeutic options mainly consisted of palliative care, chemotherapy, donor lymphocyte infusions and second transplantation in selected cases. Still many patients either do not tolerate intensive therapies or do not achieve durable remissions and will finally succumb. Given this unmet medical need the hypomethylating agents (HMA), Azacitidine (Aza) and Decitabine (DAC) have been tested as salvage therapy in patients with myeloid malignancies relapsing after allo-SCT. Furthermore, they have also been incorporated into prophylactic and pre-emptive approaches to avoid haematological relapse. In this review, we summarize the evidence from retrospective studies but also from a few prospective trials regarding the use of HMA after transplant. To aid clinicians in their daily clinical practice, we also comment on some practical aspects such as dosing and schedule, the choice of HMA and the use of complementary cellular therapies. Finally, this review also gives an overview on potential mechanisms mediating the efficacy of HMA after transplant as well as ongoing preclinical research and clinical activities aiming to further improve this treatment approach. More... »
PAGES138-150
http://scigraph.springernature.com/pub.10.1007/s12185-017-2364-4
DOIhttp://dx.doi.org/10.1007/s12185-017-2364-4
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1092687843
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/29143282
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Allografts",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Azacitidine",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Decitabine",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Administration Schedule",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Leukemia, Myeloid, Acute",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Myelodysplastic Syndromes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Recurrence",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Salvage Therapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Secondary Prevention",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Stem Cell Transplantation",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Schroeder",
"givenName": "Thomas",
"id": "sg:person.01271136615.68",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Rautenberg",
"givenName": "Christina",
"id": "sg:person.014702750321.08",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014702750321.08"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Haas",
"givenName": "Rainer",
"id": "sg:person.01127414674.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Germing",
"givenName": "Ulrich",
"id": "sg:person.01362464041.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Kobbe",
"givenName": "Guido",
"id": "sg:person.01164073234.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/leu.2011.71",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1005713196",
"https://doi.org/10.1038/leu.2011.71"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2012.256",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023636986",
"https://doi.org/10.1038/bmt.2012.256"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2011.210",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027742703",
"https://doi.org/10.1038/bmt.2011.210"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2016.274",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006297290",
"https://doi.org/10.1038/bmt.2016.274"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2009.222",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042146563",
"https://doi.org/10.1038/bmt.2009.222"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2015.325",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050370922",
"https://doi.org/10.1038/leu.2015.325"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2012.105",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050435395",
"https://doi.org/10.1038/leu.2012.105"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-012-1607-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021337269",
"https://doi.org/10.1007/s00277-012-1607-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2013.355",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016638535",
"https://doi.org/10.1038/leu.2013.355"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2015.10",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034490318",
"https://doi.org/10.1038/bmt.2015.10"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-017-3185-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1092764909",
"https://doi.org/10.1007/s00277-017-3185-5"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2015.6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015112663",
"https://doi.org/10.1038/bmt.2015.6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2013.7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019069739",
"https://doi.org/10.1038/leu.2013.7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2011.234",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037902470",
"https://doi.org/10.1038/leu.2011.234"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s13045-015-0208-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029667821",
"https://doi.org/10.1186/s13045-015-0208-3"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2013.336",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1013726992",
"https://doi.org/10.1038/leu.2013.336"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2013.233",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048090912",
"https://doi.org/10.1038/bmt.2013.233"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2009.355",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045364256",
"https://doi.org/10.1038/bmt.2009.355"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2013.193",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033380157",
"https://doi.org/10.1038/leu.2013.193"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2017.31",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1084508961",
"https://doi.org/10.1038/bmt.2017.31"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2013.64",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051101519",
"https://doi.org/10.1038/leu.2013.64"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2009.266",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026051000",
"https://doi.org/10.1038/bmt.2009.266"
],
"type": "CreativeWork"
}
],
"datePublished": "2017-11-15",
"datePublishedReg": "2017-11-15",
"description": "Despite the curative potential of allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), many patients will relapse. Until recently therapeutic options mainly consisted of palliative care, chemotherapy, donor lymphocyte infusions and second transplantation in selected cases. Still many patients either do not tolerate intensive therapies or do not achieve durable remissions and will finally succumb. Given this unmet medical need the hypomethylating agents (HMA), Azacitidine (Aza) and Decitabine (DAC) have been tested as salvage therapy in patients with myeloid malignancies relapsing after allo-SCT. Furthermore, they have also been incorporated into prophylactic and pre-emptive approaches to avoid haematological relapse. In this review, we summarize the evidence from retrospective studies but also from a few prospective trials regarding the use of HMA after transplant. To aid clinicians in their daily clinical practice, we also comment on some practical aspects such as dosing and schedule, the choice of HMA and the use of complementary cellular therapies. Finally, this review also gives an overview on potential mechanisms mediating the efficacy of HMA after transplant as well as ongoing preclinical research and clinical activities aiming to further improve this treatment approach.",
"genre": "article",
"id": "sg:pub.10.1007/s12185-017-2364-4",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1076985",
"issn": [
"0925-5710",
"1865-3774"
],
"name": "International Journal of Hematology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "2",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "107"
}
],
"keywords": [
"stem cell transplantation",
"acute myeloid leukemia",
"cell transplantation",
"myelodysplastic syndrome",
"allogeneic blood stem cell transplantation",
"blood stem cell transplantation",
"allogeneic stem cell transplantation",
"ongoing preclinical research",
"donor lymphocyte infusion",
"prevention of relapse",
"daily clinical practice",
"salvage therapy",
"haematological relapse",
"lymphocyte infusion",
"second transplantation",
"durable remissions",
"allo-SCT",
"prospective trial",
"intensive therapy",
"therapeutic options",
"palliative care",
"retrospective study",
"curative potential",
"pre-emptive approach",
"myeloid leukemia",
"clinical activity",
"treatment approaches",
"clinical practice",
"myeloid malignancies",
"patients",
"cellular therapy",
"preclinical research",
"transplantation",
"therapy",
"potential mechanisms",
"relapse",
"transplant",
"use of HMA",
"remission",
"azacitidine",
"chemotherapy",
"review",
"malignancy",
"syndrome",
"infusion",
"dosing",
"leukemia",
"decitabine",
"agents",
"clinicians",
"unmet",
"trials",
"care",
"prevention",
"efficacy",
"treatment",
"options",
"HMA",
"use",
"evidence",
"schedule",
"cases",
"activity",
"study",
"mechanism",
"practice",
"practical aspects",
"potential",
"choice",
"overview",
"approach",
"aspects",
"research"
],
"name": "Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation",
"pagination": "138-150",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1092687843"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s12185-017-2364-4"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"29143282"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s12185-017-2364-4",
"https://app.dimensions.ai/details/publication/pub.1092687843"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T17:05",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_733.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s12185-017-2364-4"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12185-017-2364-4'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12185-017-2364-4'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12185-017-2364-4'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12185-017-2364-4'
This table displays all metadata directly associated to this object as RDF triples.
302 TRIPLES
21 PREDICATES
133 URIs
102 LITERALS
19 BLANK NODES